Skip to main content

Manulife Mulfact CDN Smid Cap Idx ETF(MCSM-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Manulife Mulfact CDN Smid Cap Idx ETF down on Tuesday (MCSM)

Automated Summaries - The Globe and Mail - Tue Apr 16, 4:02PM CDT

Today during trading, shares of Manulife Mulfact CDN Smid Cap Idx ETF opened at $38.27 and closed at $38.51. Intraday prices ranged from a low of $38.27 to a high of $38.52.

Share prices shrank -0.03% from the previous day's close of $38.52.

Today across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Manulife Mulfact CDN Smid Cap Idx ETF traded under MCSM on the Toronto Stock Exchange (TSX).

A total of 529 shares was traded during the last trading day, with total trades of 6. On average, Manulife Mulfact CDN Smid Cap Idx ETF has traded 1,128 shares in the last five days and 1,680 year-to-date.

The TSX overall saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, MCSM.TO has traded as high as $39.67 (April 12,2024) and low as $33.93 (October 27,2023). Moreover, in the last 52 weeks, Manulife Mulfact CDN Smid Cap Idx ETF's shares have raised 4.00 percent, while they have boosted 6.44% since the start of 2024.

Following today's trading, Manulife Mulfact CDN Smid Cap Idx ETF has a market capitalization of $260.01 million on a float of 6,750 shares outstanding. Its annual EPS is $None.

Manulife Mulfact CDN Smid Cap Idx ETF is a None company headquartered in, None.

The Manulife Multifactor Canadian SMID Cap Index ETF seeks to track the performance of the John Hancock Dimensional Canadian SMID Cap Equity Index (CAD), before fees and expenses..

Based on 0.00 analysts, Manulife Mulfact CDN Smid Cap Idx ETF gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe